Evoke Pharma 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EV0.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Show more...
CEO
Mr. David A. Gonyer
Employees
4
Country
United States
ISIN
US30049G3020

Listings

0 Comments

Share your thoughts

FAQ

What is Evoke Pharma stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Evoke Pharma stocks are traded under the ticker EV0.STU.
How many employees does Evoke Pharma have?
As of May 06, 2026, the company has 4 employees.
In which sector is Evoke Pharma located?
Evoke Pharma operates in the Health & Wellness sector.
When did Evoke Pharma complete a stock split?
Evoke Pharma has not had any recent stock splits.
Where is Evoke Pharma headquartered?
Evoke Pharma is headquartered in Solana Beach, United States.